Denali Therapeutics Inc (DNLI) — Free Cash Flow Generation Index
Denali Therapeutics Inc (DNLI) has a Free Cash Flow Generation Index of 1.00x as of December 2020. Free cash flow of $512.72 Million represents 1% of operating cash flow ($513.91 Million). See DNLI net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Denali Therapeutics Inc Free Cash Flow Generation Index (2018–2020)
Historical FCF Generation Index trend for Denali Therapeutics Inc across 2 annual periods. Explore cash flow to debt ratio of Denali Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Denali Therapeutics Inc (2018–2020)
Year-by-year Free Cash Flow Generation Index for Denali Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Denali Therapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.99x | $413.06 Million | $416.15 Million | $3.10 Million | ▲ +6.5% |
| 2018 | 0.93x | $46.72 Million | $50.12 Million | $3.39 Million | — |